Bath & Body Works’ (BBWI) Outperform Rating Reaffirmed at Telsey Advisory Group

Telsey Advisory Group reissued their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research report released on Monday morning, Marketbeat.com reports. Telsey Advisory Group currently has a $42.00 price objective on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, FY2025 earnings at $3.28 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.

A number of other research analysts have also weighed in on the company. Barclays lowered Bath & Body Works from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $31.00 to $28.00 in a report on Friday, November 8th. BMO Capital Markets reissued an “outperform” rating and issued a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. The Goldman Sachs Group dropped their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Morgan Stanley decreased their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research note on Thursday, November 21st. Finally, Evercore ISI dropped their price target on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Stock Up 2.0 %

BBWI opened at $35.92 on Monday. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99. The company has a market cap of $7.87 billion, a PE ratio of 8.83, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79. The company has a 50-day moving average price of $30.81 and a 200 day moving average price of $35.65.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, sell-side analysts expect that Bath & Body Works will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.23%. Bath & Body Works’s payout ratio is currently 19.51%.

Insiders Place Their Bets

In other news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Bath & Body Works

Several hedge funds have recently bought and sold shares of BBWI. Anomaly Capital Management LP purchased a new stake in Bath & Body Works during the second quarter worth about $113,995,000. FMR LLC grew its holdings in shares of Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after purchasing an additional 2,501,828 shares in the last quarter. KBC Group NV increased its stake in Bath & Body Works by 9,023.5% during the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares during the period. Erste Asset Management GmbH purchased a new stake in Bath & Body Works during the 3rd quarter worth approximately $50,483,000. Finally, Lone Pine Capital LLC lifted its holdings in Bath & Body Works by 15.8% during the 2nd quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after buying an additional 1,547,399 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.